| A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity Z He, X Wan, A Schulz, H Bludau, MA Dobrovolskaia, ST Stern, ... Biomaterials 101, 296-309, 2016 | 182 | 2016 |
| Co-delivery of paclitaxel and cisplatin in poly (2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast … X Wan, JJ Beaudoin, N Vinod, Y Min, N Makita, H Bludau, R Jordan, ... Biomaterials, 2018 | 178 | 2018 |
| Drug Combination Synergy in Worm-like Polymeric Micelles Improves Treatment Outcome for Small Cell and Non-Small Cell Lung Cancer X Wan, Y Min, H Bludau, A Keith, SS Sheiko, R Jordan, AZ Wang, ... ACS nano, 2018 | 143 | 2018 |
| Poly (2-oxazoline) based micelles with high capacity for 3rd generation taxoids: Preparation, in vitro and in vivo evaluation Z He, A Schulz, X Wan, J Seitz, H Bludau, DY Alakhova, DB Darr, ... Journal of Controlled Release 208, 67-75, 2015 | 109 | 2015 |
| Poly (2‐oxazoline) block copolymer based formulations of taxanes: effect of copolymer and drug structure, concentration, and environmental factors Y Seo, A Schulz, Y Han, Z He, H Bludau, X Wan, J Tong, TK Bronich, ... Polymers for Advanced Technologies 26 (7), 837-850, 2015 | 73 | 2015 |
| Nanoparticle delivery of chemotherapy combination regimen improves the therapeutic efficacy in mouse models of lung cancer J Tian, Y Min, Z Rodgers, X Wan, H Qiu, Y Mi, X Tian, KT Wagner, ... Nanomedicine: Nanotechnology, Biology and Medicine 13 (3), 1301-1307, 2017 | 27 | 2017 |
| A High Performance Liquid Chromatography Method for the Quantitative Determination Assay of Sitagliptin in Rat Plasma and Its Application in Pharmacokinetics Study WL Xiangfei Jiu, Dewei Shang, Ye Chen, Xingang Li, Xiaomeng Wan, Tianyan Zhou Journal of Chinese Pharmaceutical Sciences 20 (1), 63-69, 2011 | 25 | 2011 |
| Poly (2-Oxazoline) Micellar Formulation For Cancer Therapy X Wan The University of North Carolina at Chapel Hill, 2018 | | 2018 |
| Tumor inhibition of poly (2-oxazoline)-paclitaxel formulations in advanced tumor models evaluated against clinical paclitaxel formulations R Luxenhofer, Z He, A Schulz, X Wan, R Jordan, A Kabanov ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 252, 2016 | | 2016 |
